Evolving role of surgical treatment in limited-disease small cell lung carcinoma

K. S. Sridhar, A. M. Hussein, Richard J Thurer

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The diagnostic role of surgical procedures in small cell lung carcinoma (SCLC) is well established. The therapeutic role of surgery has changed over the years. At present, curative resection is the treatment of choice in peripheral T1-2 N(o)M(o) SCLC, and adjuvant chemotherapy may be beneficial. Surgery is also indicated in SCLC patients diagnosed by a limited pathologic sample in whom the clinical course suggests nonsmall cell lung carcinoma (NSCLC). The resection may reveal either a mixed tumor or an alternate diagnosis and may be potentially curative. Surgery, at the time of maximal response to chemotherapy in T3N(o)M(o) SCLC, may be curative and reveal the presence of NSCLC elements. The best survival is in patients found to be tumor-free at surgery, and the worst survival is in N2 patients.

Original languageEnglish
Pages (from-to)155-161
Number of pages7
JournalJournal of Surgical Oncology
Volume40
Issue number3
StatePublished - Jan 1 1989

Fingerprint

Small Cell Lung Carcinoma
Carcinoma
Lung
Survival
Therapeutics
Adjuvant Chemotherapy
Neoplasms
Drug Therapy

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Sridhar, K. S., Hussein, A. M., & Thurer, R. J. (1989). Evolving role of surgical treatment in limited-disease small cell lung carcinoma. Journal of Surgical Oncology, 40(3), 155-161.

Evolving role of surgical treatment in limited-disease small cell lung carcinoma. / Sridhar, K. S.; Hussein, A. M.; Thurer, Richard J.

In: Journal of Surgical Oncology, Vol. 40, No. 3, 01.01.1989, p. 155-161.

Research output: Contribution to journalArticle

Sridhar, KS, Hussein, AM & Thurer, RJ 1989, 'Evolving role of surgical treatment in limited-disease small cell lung carcinoma', Journal of Surgical Oncology, vol. 40, no. 3, pp. 155-161.
Sridhar, K. S. ; Hussein, A. M. ; Thurer, Richard J. / Evolving role of surgical treatment in limited-disease small cell lung carcinoma. In: Journal of Surgical Oncology. 1989 ; Vol. 40, No. 3. pp. 155-161.
@article{6a57189be710440fb5ce789622e7b916,
title = "Evolving role of surgical treatment in limited-disease small cell lung carcinoma",
abstract = "The diagnostic role of surgical procedures in small cell lung carcinoma (SCLC) is well established. The therapeutic role of surgery has changed over the years. At present, curative resection is the treatment of choice in peripheral T1-2 N(o)M(o) SCLC, and adjuvant chemotherapy may be beneficial. Surgery is also indicated in SCLC patients diagnosed by a limited pathologic sample in whom the clinical course suggests nonsmall cell lung carcinoma (NSCLC). The resection may reveal either a mixed tumor or an alternate diagnosis and may be potentially curative. Surgery, at the time of maximal response to chemotherapy in T3N(o)M(o) SCLC, may be curative and reveal the presence of NSCLC elements. The best survival is in patients found to be tumor-free at surgery, and the worst survival is in N2 patients.",
author = "Sridhar, {K. S.} and Hussein, {A. M.} and Thurer, {Richard J}",
year = "1989",
month = "1",
day = "1",
language = "English",
volume = "40",
pages = "155--161",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Evolving role of surgical treatment in limited-disease small cell lung carcinoma

AU - Sridhar, K. S.

AU - Hussein, A. M.

AU - Thurer, Richard J

PY - 1989/1/1

Y1 - 1989/1/1

N2 - The diagnostic role of surgical procedures in small cell lung carcinoma (SCLC) is well established. The therapeutic role of surgery has changed over the years. At present, curative resection is the treatment of choice in peripheral T1-2 N(o)M(o) SCLC, and adjuvant chemotherapy may be beneficial. Surgery is also indicated in SCLC patients diagnosed by a limited pathologic sample in whom the clinical course suggests nonsmall cell lung carcinoma (NSCLC). The resection may reveal either a mixed tumor or an alternate diagnosis and may be potentially curative. Surgery, at the time of maximal response to chemotherapy in T3N(o)M(o) SCLC, may be curative and reveal the presence of NSCLC elements. The best survival is in patients found to be tumor-free at surgery, and the worst survival is in N2 patients.

AB - The diagnostic role of surgical procedures in small cell lung carcinoma (SCLC) is well established. The therapeutic role of surgery has changed over the years. At present, curative resection is the treatment of choice in peripheral T1-2 N(o)M(o) SCLC, and adjuvant chemotherapy may be beneficial. Surgery is also indicated in SCLC patients diagnosed by a limited pathologic sample in whom the clinical course suggests nonsmall cell lung carcinoma (NSCLC). The resection may reveal either a mixed tumor or an alternate diagnosis and may be potentially curative. Surgery, at the time of maximal response to chemotherapy in T3N(o)M(o) SCLC, may be curative and reveal the presence of NSCLC elements. The best survival is in patients found to be tumor-free at surgery, and the worst survival is in N2 patients.

UR - http://www.scopus.com/inward/record.url?scp=0024596914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024596914&partnerID=8YFLogxK

M3 - Article

C2 - 2537443

AN - SCOPUS:0024596914

VL - 40

SP - 155

EP - 161

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -